Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357200 · ClinicalTrials.gov registry record
Feeding Trial in the Obese Critical Care Population
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 26
- Enrollment target
NCT01357200: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT01357200 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01357200 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
Primary Outcome
on all participants
Interventions
- OTHER enteral formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-12 |
What the finished NCT01357200 record still lists
NCT01357200 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which enteral formula is the first listed.
NCT01357200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01357200 about?
NCT01357200 is a clinical study titled "Feeding Trial in the Obese Critical Care Population". This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
What is the current status of trial NCT01357200?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01357200?
The interventions under investigation include: enteral formula (OTHER).
Who is sponsoring clinical trial NCT01357200?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia